Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 21833P301
Event date: 2025-12-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Asset Management, LP
Shares: 2,344,971 · Class: 13.36%
- Chen Bihua
Shares: 2,344,971 · Class: 13.36%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-004599
- Form type
- SCHEDULE 13G/A
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Dec 15, 2025
- Reporting period
- Dec 11, 2025
- Description
- Schedule 13G beneficial ownership